UK Marketing Authorisation Holders urged to register with SecurMed UK
The Association of the British Pharmaceutical Industry (ABPI) has welcomed NHS England’s new publication summarising the recent regional workshops held on biosimilar medicines.
In a week where the Office of Health Economics (OHE) has published a report on the ten most important medicines over the life of the NHS, Dr Sheuli Porkess outlines how the pharmaceutical industry takes a substance from molecule to medicine and how the process requires persistance.
Elliot Dunster, Head of External Affairs at the ABPI, takes a closer look at the 'no deal' guidance published by Government.
Comprehensive new YouGov poll reveals majority in the UK would donate organs and blood for research and allow use of DNA and personal data to help advance healthcare
Survey shows huge pride in Britain’s history of innovation in healthcare and calls for Britain to maintain its lead
Fleming and Lister...
Enhancing the reputation of the pharmaceutical industry, improving access to innovative medicines for NHS patients and ensuring a UK environment that enables the Life Sciences industry to thrive are the three key priorities for Lisa Anson as she begins her two-year Presidency of the Association of...
The Association of the British Pharmaceutical Industry (ABPI) have responded to an announcement made today by Health Minister Lord O’Shaughnessy to spend £86 million "to help develop real world medical breakthroughs that will help patients across the NHS."
Dr Sheuli Porkess, ABPI's Head of Medical Affairs, says:
The Association of the British Pharmaceutical Industry (ABPI) and a group of leaders from ABPI member companies have joined more than 1,280 business executives, including directors from 51 FTSE 100 companies, in signing a letter backing the UK's membership of the EU.
The Association of British Pharmaceutical Industry (ABPI) welcomes the strong focus on science and innovation in the Government's green paper on Industrial Strategy, set out today by the Prime Minister. This is further demonstration of their support for research and development which is a...